Atlas Trials

Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis)

Clinical trial NCT06006689 · UNKNOWN

Trial details

NCT number
NCT06006689
Sponsor
Tasly Pharmaceutical Group Co., Ltd
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Kidney Disease
Start date
2023-09-04
Primary completion
2025-09-01
Enrollment
228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.